AU1918095A - Human prostatic specific reductase - Google Patents

Human prostatic specific reductase

Info

Publication number
AU1918095A
AU1918095A AU19180/95A AU1918095A AU1918095A AU 1918095 A AU1918095 A AU 1918095A AU 19180/95 A AU19180/95 A AU 19180/95A AU 1918095 A AU1918095 A AU 1918095A AU 1918095 A AU1918095 A AU 1918095A
Authority
AU
Australia
Prior art keywords
human prostatic
prostatic specific
specific reductase
reductase
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19180/95A
Inventor
Wei Wu He
Peter L Hudson
Paul S Meissner
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU1918095A publication Critical patent/AU1918095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
AU19180/95A 1995-01-20 1995-01-20 Human prostatic specific reductase Abandoned AU1918095A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/001827 WO1996022360A1 (en) 1995-01-20 1995-01-20 Human prostatic specific reductase

Publications (1)

Publication Number Publication Date
AU1918095A true AU1918095A (en) 1996-08-07

Family

ID=22248661

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19180/95A Abandoned AU1918095A (en) 1995-01-20 1995-01-20 Human prostatic specific reductase

Country Status (4)

Country Link
EP (1) EP0804546A4 (en)
JP (1) JPH10513044A (en)
AU (1) AU1918095A (en)
WO (1) WO1996022360A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
US6936697B2 (en) 1998-09-01 2005-08-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6156515A (en) * 1999-02-09 2000-12-05 Urocor, Inc. Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
WO2000065067A2 (en) * 1999-04-23 2000-11-02 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
CA2429199A1 (en) * 2000-05-25 2001-11-29 Incyte Genomics, Inc. Drug metabolizing enzymes
FR2814642B1 (en) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En TRANSGENIC MOUSE FOR THE TARGETED RECOMBINATION MEDIATED BY THE MODIFIED CRE-ER
GB0810097D0 (en) 2008-06-03 2008-07-09 Magnomatics Ltd Magnetic gear
EP2403963A4 (en) * 2009-03-02 2013-05-22 Agency Science Tech & Res A biomarker and treatment for cancer

Also Published As

Publication number Publication date
WO1996022360A1 (en) 1996-07-25
EP0804546A4 (en) 2000-09-20
JPH10513044A (en) 1998-12-15
EP0804546A1 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
AU5872696A (en) Endoscope
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU5896396A (en) Pyridine-microbicides
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU1182497A (en) Self-pierce rivet
AU1030997A (en) Taphane
AU7589996A (en) Cosmetics
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU1918095A (en) Human prostatic specific reductase
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU4396396A (en) Baby-bathing aid
AU5108596A (en) Morphine-3-esters
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU4334896A (en) Macerator
AU5594098A (en) Novel human carbonyl reductase
AU5188296A (en) Carbopeptoids and carbonucleotoids
AU5013796A (en) Wireclamp
AU6945596A (en) Cosmetic
AU1645599A (en) Human matrilin-3
AU5107096A (en) Haemodialyser